Fortress Biotech, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses and Other Long-Term Liabilities (Tables)

Accrued Expenses and Other Long-Term Liabilities (Tables)

3 Months Ended

Mar. 31, 2014

Payables and Accruals [Abstract]

Components of Accrued Expenses and Other Long-Term Liabilities

Accrued expenses and other long-term liabilities consisted of the following:

		As of March 31, 2014			As of December 31, 2013
Accrued expenses:
Salaries, bonuses and related benefits		$	272		$	450
Severance			993			1,502
Professional fees			280			351
Research and development expenses			1,043			1,245
State franchise taxes						190
Ovamed manufacturing rights short-term component			500			500
Lease impairment			165
Other			185			192
Total accrued expenses		$	3,438		$	4,430
Other long-term liabilities:
Hercules Note end of term charge						398
Ovamed manufacturing rights long-term component			716			679
Long-term impairment charge			350
Total other long-term liabilities		$	1,066		$	1,077